A New Financing Model for Tuberculosis (TB) Care in China: Challenges of Policy Development and Lessons Learned from...

Area of Science:

• Public Health
• Health Economics
• Health Policy

Background:

• The Chinese Center for Disease Control and Prevention (China CDC) implemented a novel financing model for tuberculosis (TB) care, supported by the Gates Foundation.
• This initiative aimed to improve TB treatment accessibility and affordability through revised policies and payment mechanisms.

Purpose of the Study:

• To review the development of financing policies and payment methods for TB care in three project sites.
• To analyze factors influencing the implementation and outcomes of the new TB financing model.

Main Methods:

• Document review of policy papers and relevant materials from project sites.
• Semi-structured qualitative interviews with stakeholders at provincial, city, and county levels.
• Thematic analysis of qualitative data to identify key themes and interpretations.

Main Results:

• The policy introduced case-based payments, increased reimbursement, and financial aid for impoverished TB patients.
• Hospitals excluded patients with complications/comorbidities, fearing costs exceeding payment ceilings.
• Actual reimbursement rates remained low, and financial burdens persisted for poor patients, despite increased service utilization.

Conclusions:

• The TB financing intervention partially succeeded in enhancing care access, particularly for poorer populations.
• Implementation faced significant challenges in an unreceptive environment, leading to deviations from the original policy design.
• The policy's primary goal of reducing patient financial burden was largely unmet due to these implementation hurdles.